<!DOCTYPE html>
<html lang="en">
  <head>
  <title>Galaxy Europe | The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia.</title>
  <meta name="description" content="The European Galaxy Instance">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">

  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/bootstrap.min.css">
  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/galaxy_bootstrap.css">
  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/main.css">
  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/academicons.min.css"/>
  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/carousel.css">




  <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/eu.css">
  
    <link rel="stylesheet" href="https://usegalaxy-eu.github.io/assets/css/freiburg.css">
  

  <link rel="canonical" href="https://usegalaxy-eu.github.io/posts/2018/07/03/circ-research-rommel/plain.html">

  <link rel="alternate" type="application/rss+xml" title="Galaxy Europe" href="https://usegalaxy-eu.github.io/feed.xml">
  <link href="https://usegalaxy-eu.github.io/assets/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">
  <script src="https://usegalaxy-eu.github.io/assets/js/jquery-3.2.1.slim.min.js" integrity="sha256-k2WSCIexGzOj3Euiig+TlR8gA0EmPjuc79OEeY5L45g=" crossorigin="anonymous"></script>
  <script src="https://usegalaxy-eu.github.io/assets/js/jquery.matchHeight-min.js" integrity="sha256-a/H26zcixe1svu2fYax7ANJMSzGYyJNI52hKKYJTar8=" crossorigin="anonymous"></script>
  <script src="https://usegalaxy-eu.github.io/assets/js/bootstrap.min.js" integrity="sha256-U5ZEeKfGNOja007MMD3YBI0A3OSZOQbeG6z2f2Y0hu8=" crossorigin="anonymous"></script>
</head>

  <body>
    <div id="wrap">
      <div id="main">
        <div class="container" id="maincontainer">
          




<section id="news-page">
  <div class="row news-header-row">
    
    <a class="col-xs-1 text-center" href="https://usegalaxy-eu.github.io/posts/2018/06/18/database-outage/plain.html">
      «
    </a>
    
    <div class="col-xs-10 ">
      <div class="text-center">
        <h2 class="title">The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia.</h2>
      </div>
      <hr />
    </div>
    
    <a class="col-xs-1 text-center" href="https://usegalaxy-eu.github.io/posts/2018/07/03/tool-usage-graphs/plain.html">
      »
    </a>
    
  </div>
  <div class="row post-metadata">
    <div class="col-md-8 col-md-offset-2">
      <div class="text-right">
        <div>
          <span class="post-date">
            Jul 3, 2018
          </span>

          

          <br />
          <span class="post-tags">
              <span class="label label-success">Freiburg</span>
            
              <span class="label label-info">paper</span>
            
          </span>

          
        </div>
      </div>
    </div>
  </div>

  <div class="row">
    <div class="col-md-8 col-md-offset-2">
      <div class="news-content">
        <p>Carolin Rommel, from the Institute of Experimental and Clinical Pharmacology and Toxicology, recently published her
manuscript about <a href="http://circres.ahajournals.org/content/early/2018/06/19/CIRCRESAHA.118.313036">“The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia”</a>.
Great work, congratulations Carolin!</p>

<div class="multiple-img">
    <img src="https://usegalaxy-eu.github.io/assets/media/ETV1.png" height="400px" alt="ETV" />
</div>

<h2 id="abstract">Abstract</h2>

<p><strong>Rationale</strong>: Structural and electrophysiological remodeling of the atria are recognized consequences
of sustained atrial arrhythmias, such as atrial fibrillation (AF). The identification of underlying
key molecules and signaling pathways has been challenging due to the changing cell type composition
during structural remodeling of the atria. <strong>Objective</strong>: Thus, the aims of our study were (1) to search
for transcription factors and downstream target genes, which are involved in atrial structural remodeling,
(2) to characterize the significance of the transcription factor ETV1 in atrial remodeling and arrhythmia and
(3) to identify ETV1-dependent gene regulatory networks in atrial cardiac myocytes. <strong>Methods and Results</strong>:
The transcription factor ETV1 was significantly upregulated in atrial tissue from patients with permanent AF.
Mice with cardiac myocyte-specific overexpression of ETV1 under control of the myosin heavy chain promoter
developed atrial dilatation, fibrosis, thrombosis and arrhythmia. Cardiac myocyte-specific ablation of ETV1
in mice did not alter cardiac structure and function at baseline. Treatment with Ang II for two weeks
elicited atrial remodeling and fibrosis in control, but not in ETV1-deficient mice. To identify
ETV1-regulated genes, cardiac myocytes were isolated and purified from mouse atrial tissue.
Active cis-regulatory elements in mouse atrial cardiac myocytes were identified by chromatin
accessibility (ATAC-seq) and the active chromatin modification H3K27ac (ChIP-seq). 178 genes
regulated by Ang II in an ETV1-dependent manner were associated with active cis-regulatory
elements containing ETV1 binding sites. Various genes involved in Ca2+ handling or gap junction
formation (Ryr2, Jph2, Gja5), potassium channels (Kcnh2, Kcnk3) as well as genes implicated in
AF (Tbx5) were part of this ETV1-driven gene regulatory network. The atrial ETV1-dependent
transcriptome in mice showed a significant overlap with the human atrial proteome of patients
with permanent AF. <strong>Conclusions</strong>: This study
dentifies ETV1 as an important component in the pathophysiology of atrial remodeling
associated with atrial arrhythmias.</p>

      </div>
    </div>
  </div>

  

</section>

        </div>
      </div>
    </div>
    





<footer class="navbar-default">
    <div class="container">
        <div class="row">
            <div class="col-lg-12" style="text-align:center">
                <p>The <a href="/freiburg/people">Freiburg Galaxy Team</a> is headed by Björn Grüning
and is part of the <a href="http://www.bioinf.uni-freiburg.de">Bioinformatics Group
Freiburg</a>, headed by Prof. Dr. Rolf
Backofen.</p>

<p>The team is part of <a href="https://www.denbi.de">de.NBI</a> and
<a href="https://www.elixir-europe.org">ELIXIR</a> and largely funded by
<a href="http://dfg.de/">DFG</a> and <a href="https://www.bmbf.de">BMBF</a>. All content on
this site is available under <a href="https://creativecommons.org/share-your-work/public-domain/cc0/">CC0-1.0</a>,
unless otherwise specified.</p>

            </div>
        </div>
        <div class="row">
            <div class="col-lg-12" style="text-align:center">
                <ul class="contact-info">
                    
                      <li><i class="fa fa-envelope"></i><a href="mailto:freiburg@usegalaxy.eu">freiburg@usegalaxy.eu</a></li>
                    
                    
                      <li><i class="fa fa-github"></i><a href="https://github.com/usegalaxy-eu">usegalaxy-eu</a></li>
                    
                    
                      <li><i class="fa fa-twitter"></i><a href="https://twitter.com/galaxyproject">galaxyproject</a></li>
                    
                      <li><i class="fa fa-rss"></i>Subscribe <a href="https://usegalaxy-eu.github.io/feed.xml">via RSS (UseGalaxy.eu Feed)</a></li>
                </ul>
            </div>
        </div>
    </div>
</footer>

  </body>
</html>
